Patents by Inventor Biao Dong

Biao Dong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240334772
    Abstract: A display substrate and a display device are provided. The display substrate includes a first power signal line and a pixel defining layer. The first power signal line includes first power signal sub-lines extending along a first direction and second power signal sub-lines extending along a second direction. The pixel defining layer includes a plurality of openings to define effective light-emitting regions of a plurality of sub-pixels, the plurality of sub-pixels include a sub-pixel pair including two sub-pixels arranged along the second direction, and the sub-pixel pair includes two effective light-emitting sub-regions with an interval therebetween. In a plan view, the first power signal sub-line passes through the interval between the two effective light-emitting sub-regions, at least one second power signal sub-line includes a fracture, and the two effective light-emitting sub-regions are located at the fracture.
    Type: Application
    Filed: June 12, 2024
    Publication date: October 3, 2024
    Applicants: CHENGDU BOE OPTOELECTRONICS TECHNOLOGY CO., LTD., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Biao LIU, Mengmeng DU, Xiangdan DONG, Hongwei MA
  • Patent number: 12101117
    Abstract: This application provides a port identification method, apparatus, and system, and belongs to the field of optical communications technologies. According to this application, a connection relationship between the ONT and the optical splitter and a connection relationship between the ONT and the port of the optical splitter can be accurately identified.
    Type: Grant
    Filed: December 18, 2022
    Date of Patent: September 24, 2024
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Zhenhua Dong, Xiaolong Dong, Biao Qi
  • Patent number: 12099240
    Abstract: A splitter includes an optical input section, N optical branch sections, and at least (N?1) optical filter structures. Each optical filter structure reflects an optical signal of one wavelength. The at least (N?1) optical filter structures include a special optical filter structure and at least (N?3) common optical filter structures, and a wavelength of an optical signal reflected by each of the common optical filter structures is a common wavelength. A wavelength of an optical signal reflected by a first/second special optical filter structure is a first/second special wavelength. At least (N?3) common wavelengths constitute an arithmetic sequence, a difference between the first special wavelength and a largest common wavelength is greater than a tolerance of the arithmetic sequence, and a difference between the second special wavelength and a smallest common wavelength is greater than the tolerance of the arithmetic sequence.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: September 24, 2024
    Assignee: Huawei Technologies Co., Ltd.
    Inventors: Biao Qi, Qi Zhang, Zhenhua Dong
  • Patent number: 12101973
    Abstract: A display substrate and a display device are provided. The display substrate includes a first power signal line and a pixel defining layer. The first power signal line includes first power signal sub-lines extending along a first direction and second power signal sub-lines extending along a second direction. The pixel defining layer includes a plurality of openings to define effective light-emitting regions of a plurality of sub-pixels, the plurality of sub-pixels include a sub-pixel pair including two sub-pixels arranged along the second direction, and the sub-pixel pair includes two effective light-emitting sub-regions with an interval therebetween. In a plan view, the first power signal sub-line passes through the interval between the two effective light-emitting sub-regions, at least one second power signal sub-line includes a fracture, and the two effective light-emitting sub-regions are located at the fracture.
    Type: Grant
    Filed: April 26, 2020
    Date of Patent: September 24, 2024
    Assignees: CHENGDU BOE OPTOELECTRONICS TECHNOLOGY CO., LTD., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Biao Liu, Mengmeng Du, Xiangdan Dong, Hongwei Ma
  • Patent number: 12063827
    Abstract: A display substrate and a display device are provided. The display substrate includes a first power signal line and a pixel defining layer. The first power signal line includes first power signal sub-lines extending along a first direction and second power signal sub-lines extending along a second direction. The pixel defining layer includes a plurality of openings to define effective light-emitting regions of a plurality of sub-pixels, the plurality of sub-pixels include a sub-pixel pair including two sub-pixels arranged along the second direction, and the sub-pixel pair includes two effective light-emitting sub-regions with an interval therebetween. In a plan view, the first power signal sub-line passes through the interval between the two effective light-emitting sub-regions, at least one second power signal sub-line includes a fracture, and the two effective light-emitting sub-regions are located at the fracture.
    Type: Grant
    Filed: April 26, 2020
    Date of Patent: August 13, 2024
    Assignees: CHENGDU BOE OPTOELECTRONICS TECHNOLOGY CO., LTD., BOE TECHNOLOGY GROUP CO., LTD.
    Inventors: Biao Liu, Mengmeng Du, Xiangdan Dong, Hongwei Ma
  • Publication number: 20240268169
    Abstract: A display substrate and a manufacturing method thereof, and a display device are disclosed. The display substrate includes a base substrate, a plurality of sub-pixels, at least one group of contact pads, and a first insulation layer. The base substrate includes a display region and a bonding region located at one side of the display region. At least one group of contact pads includes a plurality of contact pads, at least one of the plurality of contact pads includes a first contact pad metal layer and a second contact pad metal layer, the second contact pad metal layer covers an edge of the first contact pad metal layer. The first insulation layer is located in gaps between the plurality of contact pads and covers edges of the plurality of contact pads, and is configured to expose surfaces of the plurality of contact pads facing away from the base substrate.
    Type: Application
    Filed: March 27, 2024
    Publication date: August 8, 2024
    Inventors: Mengmeng DU, Xiangdan DONG, Hongwei MA, Jun YAN, Bo CHENG, Biao LIU
  • Publication number: 20240254197
    Abstract: The present invention relates to an engineered human factor VIII polypeptide, which includes at least two substituted amino acids in A1 domain of hFVIII. In some embodiments, the substituted amino acids comprise L50V and L152P. In some embodiments, the substituted amino acids further comprise one or more of amino acid substitutions selected from the group consisting of D20S, G22L, I61T, D115E, F129I, G132D, Q139E, and L159F. The present invention also relates to engineered hFVIII polypeptide encoding nucleic acid fragment, an expression vector or a rAAV vector contains such nucleic acid fragment, and a method of using engineered hFVIII polypeptide to treat hemophilia A patients.
    Type: Application
    Filed: February 11, 2022
    Publication date: August 1, 2024
    Applicant: Sichuan Real&Best Biotech Co., Ltd.
    Inventors: Biao Dong, Bo Zhang, Jingya Ye, Lin Xiao, Zhaoyue Zheng, Li Yang, Yu Liu
  • Publication number: 20240260342
    Abstract: A display panel includes: a base substrate, a third conductive layer, and a fourth conductive layer. The third conductive layer is located on one side of the base substrate and includes multiple first signal lines, where orthographic projections of the first signal lines on the base substrate are spaced apart in a first direction and extend along a second direction, and the first direction intersects with the second direction. The fourth conductive layer is located on the side of the third conductive layer away from the base substrate and includes multiple connection line segments, where orthographic projections of the connection line segments on the base substrate extend along the first direction, and a same connection line segment is respectively connected to a plurality of first signal lines through via holes.
    Type: Application
    Filed: August 24, 2021
    Publication date: August 1, 2024
    Inventors: Youngyik KO, Mengmeng DU, Xiangdan DONG, Biao LIU, Xiaoqing SHU, Hongwei MA
  • Patent number: 12052889
    Abstract: An array substrate is provided. The array substrate includes a node connecting line in a same layer as a respective voltage supply line, connected to a first capacitor electrode and a semiconductor material layer. An orthographic projection of a first anode on a base substrate at least partially overlaps with an orthographic projection of a node connecting line in a respective first subpixel. An orthographic projection of a second anode on the base substrate at least partially overlaps with an orthographic projection of the node connecting line in a respective second subpixel. An orthographic projection of a third anode on the base substrate at least partially overlaps with an orthographic projection of the node connecting line in a respective third subpixel. An orthographic projection of a fourth anode on the base substrate at least partially overlaps with an orthographic projection of the node connecting line in a respective fourth subpixel.
    Type: Grant
    Filed: November 10, 2020
    Date of Patent: July 30, 2024
    Assignees: Chengdu BOE Optoelectronics Technology Co., Ltd., BOE Technology Group Co., Ltd.
    Inventors: Yixuan Long, Biao Liu, Mengmeng Du, Xiaoqing Shu, Hongwei Ma, Yujing Li, Xiangdan Dong, Siyu Wang
  • Publication number: 20220144919
    Abstract: In one aspect, present invention provides a recombinant mutant human factor VIII having increased expression and/or secretion as compared to wild-type factor VIII. In certain embodiments, the recombinant factor VIII includes one or more amino acid substitution(s) selected from the group consisting of 186, Y105, A108, D115, Q117, F129, G132, H134, M147 and L152. In other aspects, the present invention provides FVIII encoding nucleic acids, FVIII-expression vectors, as well as methods of using the modified FVIII genes in the treatment of FVIII deficiencies, such as hemophilia A.
    Type: Application
    Filed: January 24, 2022
    Publication date: May 12, 2022
    Applicant: IVYGEN CORPORATION
    Inventors: Weidong XIAO, Wenjing CAO, Biao DONG
  • Patent number: 11261234
    Abstract: In one aspect, present invention provides a recombinant mutant human factor VIII having increased expression and/or secretion as compared to wild-type factor VIII. In certain embodiments, the recombinant factor VIII includes one or more amino acid substitution(s) selected from the group consisting of I86, Y105, A108, D115, Q117, F129, G132, H134, M147 and L152. In other aspects, the present invention provides FVIII encoding nucleic acids, FVIII-expression vectors, as well as methods of using the modified FVIII genes in the treatment of FVIII deficiencies, such as hemophilia A.
    Type: Grant
    Filed: October 18, 2018
    Date of Patent: March 1, 2022
    Assignee: IVYGEN CORPORATION
    Inventors: Weidong Xiao, Wenjing Cao, Biao Dong
  • Publication number: 20190177399
    Abstract: In one aspect, present invention provides a recombinant mutant human factor VIII having increased expression and/or secretion as compared to wild-type factor VIII. In certain embodiments, the recombinant factor VIII includes one or more amino acid substitution(s) selected from the group consisting of I86, Y105, A108, D115, Q117, F129, G132, H134, M147 and L152. In other aspects, the present invention provides FVIII encoding nucleic acids, FVIII-expression vectors, as well as methods of using the modified FVIII genes in the treatment of FVIII deficiencies, such as hemophilia A.
    Type: Application
    Filed: October 18, 2018
    Publication date: June 13, 2019
    Applicant: IVYGEN CORPORATION
    Inventors: Weidong Xiao, Wenjing Cao, Biao Dong
  • Patent number: D779783
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: February 28, 2017
    Inventor: Biao Dong